GW Pharmaceuticals Gets Orphan Drug Status For Cannabidiol, Stock Rises

GW Pharmaceuticals PLC (NASDAQ: GWPH) disclosed that FDA has accorded Orphan Drug Designation for its Cannabidiol for the treatment ...